Publications by authors named "Eran P Klein"
Background: Pharmaceutical industry financial support of physicians, physician practices, and academic departments involved in multicenter industry-sponsored clinical trials of novel therapeutic agents is a relatively new and infrequently acknowledged source of potential physician conflict of interest. Detailed disclosure of these relationships to study participants is not uniformly a part of informed consent and documentation practices.
Objective: To understand attitudes of patients with multiple sclerosis concerning disclosure of potential physician-industry conflicts of interest created by clinical trials and how such disclosures may influence study participation
Methods: An anonymous online instrument was developed.
Background: Patient incentives for encouraging healthy behavior raise a number of ethical concerns: Do they target the vulnerable? Do they involve psychological manipulation? Do they undermine intrinsic motivation?
Purpose: To the purpose of this paper is to provide an overview of ethical challenges raised by patient incentives and incentive programs and develop a systematic approach to understanding and analyzing these ethical challenges.
Method: Ethical considerations raised by patient incentives can be broadly grouped into two kinds: medical ("patient-oriented") and public health ("constituent-oriented") concerns. Ethical frameworks suitable to these kinds of concerns are explored.
The goal of this study was to describe the attitudes of U.S. neurologists specializing in dementia toward the use of amyloid imaging in the diagnosis of Alzheimer's disease (AD).
View Article and Find Full Text PDFObjective: To describe the clinical characteristics of encounters with patients misdiagnosed with multiple sclerosis (MS).
Methods: A cross-sectional Internet-based physician survey of MS specialists was performed.
Results: The response rate for the survey was 50.